Metraipolis › archive › dc_fb35283237b1

An in situ generated CAR-M with IFN-γ and negative dominance Sirpα isoform augments hepatocellular carcinoma immunotherapy — Europe PMC PMID:42192422

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42192422
DOI
10.1186/s12951-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-01T07:39:55.627Z
SHA-256 of the archived text
824dfd24f56be92e57bd2c35be5028d30fd819ab082a0b7f867e6278efac5330
Stable URL of this page
https://metraipolis.com/documento/dc_fb35283237b1

How to cite

An in situ generated CAR-M with IFN-γ and negative dominance Sirpα isoform augments hepatocellular carcinoma immunotherapy — Europe PMC PMID:42192422 — Europe PMC (en), https://europepmc.org/article/MED/42192422 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb35283237b1 (Metraipolis archive dc_fb35283237b1, sha256 824dfd24f56be92e57bd2c35be5028d30fd819ab082a0b7f867e6278efac5330)
BibTeX
@misc{dcfb35283237b1,
  title = {An in situ generated CAR-M with IFN-γ and negative dominance Sirpα isoform augments hepatocellular carcinoma immunotherapy — Europe PMC PMID:42192422},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42192422},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb35283237b1; sha256 824dfd24f56be92e57bd2c35be5028d30fd819ab082a0b7f867e6278efac5330},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42192422. Agents can read the archived copy with the MCP tool read_document.